Portal de Periódicos da CAPES

Artigo Produção Nacional Revisado por pares

BIBTEX RIS

Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial

2025; Elsevier BV; Linguagem: Inglês

10.1016/s0140-6736(24)02848-4

1474-547X

Thierry André, Elena Élez, Heinz‐Josef Lenz, Lars Henrik Jensen, Yann Touchefeu, Eric Van Cutsem, Rocio García‐Carbonero, David Tougeron, Guillermo Ariel Mendez, Michael Schenker, Christelle de la Fouchardière, María Luisa Limón, Takayuki Yoshino, Jin Li, José Luis Manzano Mozo, Laëtitia Dahan, Giampaolo Tortora, Myriam Chalabi, Eray Goekkurt, Maria Ignez Braghiroli, Rohit Joshi, Timuçin Çil, F. Aubin, Elvis Cela, Tian Chen, Ming Lei, Lixian Jin, Steven I. Blum, Sara Lonardi,

Cancer Immunotherapy and Biomarkers